Cytotoxic Antibodies and Kidney Transplant Survival
Author Information
Author(s): Moise AM, Nedelcu D, Toader A, Sora M, Tica A, Ferastraoaru DE, Constantinescu I
Primary Institution: Carol Davila Medical University, Immunology of Transplantation, Fundeni–Centre for Immunogenetics and Virology, Bucharest, Romania
Hypothesis
Can cytotoxic antibodies predict long-term kidney allograft survival?
Conclusion
Patients post-kidney transplantation are at high risk of developing cytotoxic antibodies, especially if there is an HLA mismatch with the donor, which can predict acute graft rejection and graft failure.
Supporting Evidence
- 29% of patients were sensitized before transplantation.
- De novo antibodies were most common in the first 6 months post-transplant.
- 86% of transplant recipients experienced at least one episode of acute rejection.
Takeaway
After getting a kidney transplant, some patients can develop harmful antibodies that might make their new kidney fail, especially if their body doesn't match the donor well.
Methodology
The study evaluated 500 Romanian patients on the kidney transplant waiting list, screening for anti-HLA class I and II antibodies using ELISA and Luminex methods.
Limitations
The study is limited to Romanian patients and may not be generalizable to other populations.
Participant Demographics
500 Romanian patients registered on the kidney transplant waiting list.
Want to read the original?
Access the complete publication on the publisher's website